Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 12, 2006
Complex insulin-treated diabetic population shows numerical trend toward improved MACE outcomes with TAXUS versus Cypher
-
Mar 12, 2006
TAXUS trials continue to deliver positive outcomes in complex cases
-
Mar 10, 2006
Team will lead CRM Group following acquisition of Guidant
-
Mar 8, 2006
Completes Company's application for FDA approval
-
Mar 7, 2006Results highlight efficacy of TAXUS in most complex lesions and highest risk patients
Results highlight efficacy of TAXUS in most complex lesions and highest risk patients
-
Mar 3, 2006
A live webcast and replay of the March 9 conference session will be available
-
Mar 2, 2006
Shareholders of both companies to vote on March 31, 2006
-
Mar 1, 2006
A live webcast and replay of the March 7 conference session will be available
-
Feb 15, 2006
(February 15, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS
-
Feb 3, 2006
"We reviewed with the FDA a path to resolve the issues they have identified, and we committed to working closely with them to ensure they are resolved," said Tobin
-
Feb 1, 2006
A live webcast and replay of the February 8 conference session will be available
-
Jan 31, 2006
A live webcast and replay of the February 7 conference call will be available
-
Jan 25, 2006
Merger agreement to combine the two companies, creating one of the largest medical technology companies in the world
-
Jan 18, 2006
Study was presented at the Association for Vascular Access (AVA) Annual Conference in Savannah, GA
-
Jan 5, 2006
(January 5, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin has agreed to a request from the Board of Directors to extend...
-
Jan 4, 2006
New device pass-through code is only intended for use in the hospital outpatient setting under Medicare
-
Dec 31, 2005
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005.
-
Dec 21, 2005
(December 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced it has made a $250,000 gift to Doctors Without Borders, an international medical humanitarian organization, in...
-
Dec 14, 2005
(December 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced a $500,000 contribution to the University of Minnesota Foundation to fund the creation of a Boston Scientific...
-
Dec 6, 2005
(December 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that two of its senior executives are scheduled to participate in the first annual Massachusetts Conference for...
-
Nov 23, 2005
(November 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday,...
-
Nov 17, 2005
(November 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $750 million aggregate principal amount of its senior notes under the Company
-
Nov 10, 2005
(November 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, randomized,...
-
Nov 8, 2005
and Vancouver, B.C. (November 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) announced today that they have jointly received the...
-
Oct 31, 2005
(October 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Sixteenth Annual Healthcare Conference, which is being held November 7-9 in...